Lactobacillus brevis SBC8803 and No Direct Health Outcome Reported

• Paradoxical Reactions to Anti-TNFα and Anti-IL-17 Treatment in Psoriasis Patients: Are Skin and/or Gut Microbiota Involved?

  • 2023-03-15
  • Review
  • Dermatology and therapy 13(4)
  • • Zuzana Jiraskova Zakostelska
    • Zuzana Reiss
    • Helena Tlaskalova-Hogenova
    • Filip Rob

  • PubMed: 36929119
  • DOI: 10.1007/s13555-023-00904-4

  4 Insights on

  • No Direct Health Outcome Reported

  • Low evidence

  The provided abstract discusses psoriasis, barrier defects, microbiota, and paradoxical reactions to biologic treatments, but it does not mention Lactobacillus brevis SBC8803 or report any outcomes from consuming it.

  Effect

  Neutral

  Effect size

  Small